UCSF University of California, San Francisco      About UCSF       Search UCSF       UCSF Medical Center     
School of Medicine  
 
 
UCSF-Stanford Lysosomal Disease Center
Staff at the Center
Gaucher Disease
Fabry Disease
Hurler Syndrome
Niemann-Pick Disease
Maps
Meetings and Events
Newsletters and Publications
 

Gaucher Disease Overview

Gaucher disease (pronounced "go-shay") type 1 is the most common lysosomal disease. It affects up to 1 in 600 people of Ashkenazi Jewish descent and about 1 in 40,000 people of other ethnicities. Gaucher disease is caused by an absence or shortage of the enzyme glucocerebrosidase ("gloo-ko-sir-e-bro-sy-daze"), which normally breaks down the chemical glucocerebroside into glucose (a sugar) and ceramide (a fat). This chemical breakdown happens in the lysosomes of macrophages, a type of white blood cell. If the glucocerebrosidase enzyme is absent or in short supply, the substance glucocerebroside cannot be broken down. Instead, glucocerebroside builds up in the lysosomes of the macrophages in the liver, spleen, bones, and other organs of the body. These enlarged macrophages are sometimes called Gaucher cells.

The build-up of glucocerebroside results in Gaucher disease. Symptoms include bleeding problems, enlargement of the liver and spleen, bone abnormalities, and (occasionally) lung problems. The symptoms of Gaucher disease vary from person to person, may be mild or severe, and can appear at any time from infancy to old age. Lifespan in people with Gaucher disease is generally normal.

  Common Symptoms:
  • Frequent nosebleeds
  • Easy bleeding and/or bruising
  • Tiredness
  • Bone pain
  • Frequent bone fractures
  • Enlarged spleen and/or liver

These symptoms suggest the possibility of type 1 Gaucher disease. More than 99% of people with Gaucher disease have Type 1. People with type 2 or type 3 Gaucher disease have brain symptoms in addition to the above symptoms.

 
Gaucher disease
type 1
Gaucher disease
type 2
Gaucher disease
type 3
Frequency of disease
Ashkenazi Jews:
1/500-1/1500
Other ethnicities:
1/40,000-1/60,000
<1/100,000
1/50,000-1/100,000
Ethnicity of affected individuals
Any, but more common in people of Ashkenazi Jewish ancestry
Any
Any, but more common in people of Norbotten Swedish ancestry
Age of onset
Any age
Infancy
Childhood
Lifespan
6 to 80+ years
~2 years
2-60 years
Brain symptoms
No
Yes,
severe
Yes,
mild to severe
Liver/spleen symptoms
Yes
Yes
Yes
Blood symptoms
Yes,
mild to severe
Yes,
severe
Yes,
mild to severe
Bone symptoms
Yes,
mild to severe
No
Yes,
mild to severe

    Site Map    Contact Info     ©UC Regents